Eva Pharma
Eva Pharma, a leading pharmaceutical company headquartered in Egypt, has established itself as a key player in the healthcare industry since its founding in 1997. With a strong presence across the Middle East and North Africa, the company focuses on developing, manufacturing, and marketing a diverse range of innovative medicines and healthcare solutions. Specialising in therapeutic areas such as oncology, cardiology, and infectious diseases, Eva Pharma is renowned for its commitment to quality and patient care. The company’s core products include both prescription medications and over-the-counter solutions, distinguished by their efficacy and safety profiles. Recognised for its significant contributions to the pharmaceutical landscape, Eva Pharma has achieved numerous milestones, including partnerships with global organisations and a robust pipeline of new therapies. With a dedication to advancing healthcare, Eva Pharma continues to enhance its market position through innovation and excellence.
DitchCarbon Score
How does Eva Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eva Pharma's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eva Pharma's reported carbon emissions
Eva Pharma, headquartered in Egypt (EG), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints, indicating that Eva Pharma may be aligning with broader industry trends. As the company progresses, it will be essential to monitor any future announcements regarding emissions data and climate commitments to better understand their environmental impact and sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eva Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
